Journal profile · ONCOLOGY-GERIATRICS & GERONTOLOGY
Journal of Geriatric Oncology
ISSN 1879-4068 · eISSN 1879-4076 · Elsevier Ltd · NETHERLANDS · Founded 2010
Journal of Geriatric Oncology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.89; hybrid open access; APC about USD 3,610; median 136 days to acceptance (110 articles, last 24 months); community-reported acceptance: easy; 444 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Geriatric Oncology is published by Elsevier Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Frailty in Older Adults, Cancer survivorship and care and Nutrition and Health in Aging, together about 48.9% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology.Editor-in-Chief, Supriya Mohile, University of Rochester, USA and the Editorial Board invite you to submit a manuscript to the Journal of Geriatric Oncology. The journal welcomes the submission of manuscripts in the following categories:• Original research articles • Review articles • Clinical trials • Education and training articles • Short communications • Perspectives • Meeting reports • Letters to the EditorThe Journal of Geriatric Oncology is the official journal of the International Society of Geriatric Oncology (SIOG).Journal of Geriatric Oncology's Inclusion and Diversity Pledge This journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader?ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY-GERIATRICS & GERONTOLOGY
Editor-in-chief Supriya MohilePublisher website
Editorial board by country: none in mainland China; most named United States 55, Australia 7, Belgium 5, France 4, Canada 4 (97 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Frailty in Older AdultsMedicine24.4%
- Cancer survivorship and careMedicine12.4%
- Nutrition and Health in AgingMedicine12.1%
- Palliative Care and End-of-Life IssuesMedicine6.3%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance5.2%
- Cancer-related cognitive impairment studiesMedicine3.3%
- Economic and Financial Impacts of CancerEconomics, Econometrics and Finance3%
- Cancer Treatment and PharmacologyMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Geriatrics & Gerontology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Geriatrics & Gerontology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Geriatrics & Gerontology | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.89LetPub ·
- Impact factor (publisher)
- 2.9Publisher website ·
- CiteScore 2026-06
- 4.4LetPub ·
- CiteScore (publisher)
- 4.4Publisher website ·
- SJR 2026-06
- 0.94LetPub ·
- SNIP 2026-06
- 0.84LetPub ·
- h-index
- 27LetPub ·
- h-index
- 75OpenAlex ·
- i10-index
- 917OpenAlex ·
- 2-year mean citedness
- 0.96OpenAlex ·
- Self-citation rate
- 13.8%LetPub ·
- Share of gold OA articles
- 24.14%LetPub ·
Volume
- Articles per year
- 118LetPub ·
Articles by year OpenAlex count · 4,160 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 214 | 74 | 44 |
| 2025 | 444 | 97 | 287 |
| 2024 | 385 | 101 | 672 |
| 2023 | 383 | 121 | 1,317 |
| 2022 | 355 | 93 | 2,090 |
| 2021 | 340 | 111 | 2,217 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
136 daysMedian, submission to acceptance · P25–P75 76 days – 217 days
- Acceptance to online
- median 8 days (110 articles)
- Submission to online
- median 145 days
- Sample
- 110 articles with submission and acceptance dates (414 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 50 daysPublisher website ·
- Submission to acceptance
- 128 daysPublisher website ·
- Acceptance to publication
- 10 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,610 / EUR 3,380 / GBP 2,890 / JPY 447,750 | — | — | |
| Publisher website | USD 3,880 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 350 words
- Keywords
- 1–7
- Manuscript length
- ≤ 3,500 words
- Reference style
- Numbered, in order of citation
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Required
Article types accepted20, with length limits
- clinical trial protocolClinical Trial Protocol: Clinical trial protocols are considered as long as they focus on and have a strong clinical relevance to older adults with cancer.Length not stated
- editorialThe Journal of Geriatric Oncology publishes articles in the following categories: Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not h…Length not stated
- editorialsEditorials: Editorials are invited by the Editor-in-Chief. Editorials do not have an abstract or keywords and should be limited to 1,500 words in length.Length not stated
- letternot covered in other section. Research Letters: Research letters of 1,500 words or less can provide a brief overview of original research.main text ≤ 1,500 words
- letters to the editores, and should not include an abstract. Letters to the Editor: Letters of 1,500 words or less which relate to previously published work from themain text ≤ 1,500 words
- meeting reportsMeeting Reports: Reports on geriatric oncology conferences, meetings and workshops are welcomed, although authors are recommended to discuss their proposal firs…Length not stated
- meta-analysisThe Journal of Geriatric Oncology publishes articles in the following categories: Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not h…Length not stated
- narrative reviewThe Journal of Geriatric Oncology publishes articles in the following categories: Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not h…Length not stated
- original researchThe Journal of Geriatric Oncology publishes articles in the following categories: Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not h…Length not stated
- original research articleThe Journal of Geriatric Oncology publishes articles in the following categories: Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not h…Length not stated
- original research articlesOriginal Research Articles: Original, full-length research papers which have not been published previously may be submitted.Length not stated
- original research paperThe Journal of Geriatric Oncology publishes articles in the following categories: Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not h…Length not stated
- perspectiveThe Journal of Geriatric Oncology publishes articles in the following categories: Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not h…Length not stated
- perspectivesPerspectives: Perspectives papers are invited or approved by the Editor-in-Chief.Length not stated
- research paperThe Journal of Geriatric Oncology publishes articles in the following categories: Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not h…Length not stated
- reviewThe Journal of Geriatric Oncology publishes articles in the following categories: Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not h…Length not stated
- review articleThe Journal of Geriatric Oncology publishes articles in the following categories: Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not h…Length not stated
- review articlesReview Articles: Review articles which are topical and which are a critical assessment of any aspect of geriatric oncology may be submitted.Length not stated
- systematic reviewThe Journal of Geriatric Oncology publishes articles in the following categories: Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not h…Length not stated
- systematic reviewsSystematic reviews: Systematic Reviews with or without a meta-analyses are preferred over narrative reviews.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Keywords: 1 to 7 required Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Ethics: follow Elsevier's Publishing Ethics Policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Peer review type: single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed; will not count as prior publication Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Ltd
- Country or region
- NETHERLANDS
- Language
- English
- Founded
- 2010
- ISSN
- 1879-4068
- Electronic ISSN
- 1879-4076
- Society / sponsor
- International Society of Geriatric Oncology
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Geriatric Oncology
What CAS zone is Journal of Geriatric Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Geriatric Oncology is in Zone 3 of Medicine, and in Zone 3 of the minor category Oncology / Geriatrics & Gerontology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Geriatric Oncology?
The latest impact factor listed by LetPub is 2.89; CiteScore 4.4, h-index 75.
How long does peer review take at Journal of Geriatric Oncology?
Based on the dates recorded on 110 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 136 days (interquartile range 76–217 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Geriatric Oncology?
According to the journal's author guidelines: Abstract: ≤ 350 words; Keywords: 1–7; Manuscript length: ≤ 3,500 words; Reference style: Numbered, in order of citation; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Geriatric Oncology based?
Of the 97 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (55), Australia (7) and Belgium (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Geriatric Oncology?
According to LetPub and DOAJ records, Journal of Geriatric Oncology is indexed in SCIE and Scopus.
Is Journal of Geriatric Oncology open access, and what is the APC?
Journal of Geriatric Oncology is a hybrid journal. For open-access publication: APC about USD 3,610.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .